Veru Inc.

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Veru Inc., Biotechnology company, 2916 North Miami Avenue, Miami, FL.

Veru is a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases

05/13/2026

https://ir.verupharma.com/news-events/press-releases/detail/254/veru-reports-fiscal-2026-second-quarter-financial-results

--Phase 2b PLATEAU clinical study evaluating enobosarm + semaglutide is actively enrolling and on track for interim analysis first quarter…...

05/06/2026

https://ir.verupharma.com/news-events/press-releases/detail/253/veru-to-report-fiscal-2026-second-quarter-financial-results

MIAMI, FL, May 06, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…...

03/09/2026

https://ir.verupharma.com/news-events/press-releases/detail/252/veru-enrolls-first-patient-in-phase-2b-plateau-clinical

-- The Phase 2b study to assess enobosarm’s ability to preserve lean mass, physical function, and bone as well as burn more fat to produce…...

02/19/2026

https://ir.verupharma.com/news-events/press-releases/detail/251/veru-to-present-at-the-oppenheimer-36th-annual-healthcare

MIAMI, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing…...

02/11/2026

https://ir.verupharma.com/news-events/press-releases/detail/250/veru-reports-fiscal-2026-first-quarter-financial-results

-- Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate…...

02/04/2026

https://ir.verupharma.com/news-events/press-releases/detail/249/veru-to-report-fiscal-2026-first-quarter-financial-results

MIAMI, FL, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…...

12/17/2025

https://ir.verupharma.com/news-events/press-releases/detail/248/veru-reports-fiscal-year-2025-financial-results-and

-- Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in…...

12/10/2025

https://ir.verupharma.com/news-events/press-releases/detail/247/veru-to-report-fiscal-year-2025-financial-results-on

MIAMI, FL, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…...

12/04/2025

https://ir.verupharma.com/news-events/press-releases/detail/246/veru-to-present-at-the-society-on-sarcopenia-cachexia-and

MIAMI, FL, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…...

10/31/2025

https://ir.verupharma.com/news-events/press-releases/detail/245/veru-to-present-two-abstracts-at-obesityweek-2025

MIAMI, FL, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…...

Address

2916 North Miami Avenue
Miami, FL
33137

Website

http://www.VeruPharma.com/

Alerts

Be the first to know and let us send you an email when Veru Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Christina Archer Consulting

Want your business to be the top-listed Business in Miami?